USANA Health Sciences Inc
NYSE:USNA

Watchlist Manager
USANA Health Sciences Inc Logo
USANA Health Sciences Inc
NYSE:USNA
Watchlist
Price: 38.05 USD -0.5% Market Closed
Market Cap: 725.2m USD
Have any thoughts about
USANA Health Sciences Inc?
Write Note

Intrinsic Value

The intrinsic value of one USNA stock under the Base Case scenario is 42.6 USD. Compared to the current market price of 38.05 USD, USANA Health Sciences Inc is Undervalued by 11%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

USNA Intrinsic Value
42.6 USD
Undervaluation 11%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
USANA Health Sciences Inc

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Valuation History Unavailable

Historical valuation for USNA cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about USNA?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

AI Assistant
AI Assistant
Ask me anything about USANA Health Sciences Inc

Provide an overview of the primary business activities
of USANA Health Sciences Inc.

What unique competitive advantages
does USANA Health Sciences Inc hold over its rivals?

What risks and challenges
does USANA Health Sciences Inc face in the near future?

Has there been any significant insider trading activity
in USANA Health Sciences Inc recently?

Summarize the latest earnings call
of USANA Health Sciences Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for USANA Health Sciences Inc.

Provide P/S
for USANA Health Sciences Inc.

Provide P/E
for USANA Health Sciences Inc.

Provide P/OCF
for USANA Health Sciences Inc.

Provide P/FCFE
for USANA Health Sciences Inc.

Provide P/B
for USANA Health Sciences Inc.

Provide EV/S
for USANA Health Sciences Inc.

Provide EV/GP
for USANA Health Sciences Inc.

Provide EV/EBITDA
for USANA Health Sciences Inc.

Provide EV/EBIT
for USANA Health Sciences Inc.

Provide EV/OCF
for USANA Health Sciences Inc.

Provide EV/FCFF
for USANA Health Sciences Inc.

Provide EV/IC
for USANA Health Sciences Inc.

Show me price targets
for USANA Health Sciences Inc made by professional analysts.

What are the Revenue projections
for USANA Health Sciences Inc?

How accurate were the past Revenue estimates
for USANA Health Sciences Inc?

What are the Net Income projections
for USANA Health Sciences Inc?

How accurate were the past Net Income estimates
for USANA Health Sciences Inc?

What are the EPS projections
for USANA Health Sciences Inc?

How accurate were the past EPS estimates
for USANA Health Sciences Inc?

What are the EBIT projections
for USANA Health Sciences Inc?

How accurate were the past EBIT estimates
for USANA Health Sciences Inc?

Compare the revenue forecasts
for USANA Health Sciences Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of USANA Health Sciences Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of USANA Health Sciences Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of USANA Health Sciences Inc compared to its peers.

Compare the P/E ratios
of USANA Health Sciences Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing USANA Health Sciences Inc with its peers.

Analyze the financial leverage
of USANA Health Sciences Inc compared to its main competitors.

Show all profitability ratios
for USANA Health Sciences Inc.

Provide ROE
for USANA Health Sciences Inc.

Provide ROA
for USANA Health Sciences Inc.

Provide ROIC
for USANA Health Sciences Inc.

Provide ROCE
for USANA Health Sciences Inc.

Provide Gross Margin
for USANA Health Sciences Inc.

Provide Operating Margin
for USANA Health Sciences Inc.

Provide Net Margin
for USANA Health Sciences Inc.

Provide FCF Margin
for USANA Health Sciences Inc.

Show all solvency ratios
for USANA Health Sciences Inc.

Provide D/E Ratio
for USANA Health Sciences Inc.

Provide D/A Ratio
for USANA Health Sciences Inc.

Provide Interest Coverage Ratio
for USANA Health Sciences Inc.

Provide Altman Z-Score Ratio
for USANA Health Sciences Inc.

Provide Quick Ratio
for USANA Health Sciences Inc.

Provide Current Ratio
for USANA Health Sciences Inc.

Provide Cash Ratio
for USANA Health Sciences Inc.

What is the historical Revenue growth
over the last 5 years for USANA Health Sciences Inc?

What is the historical Net Income growth
over the last 5 years for USANA Health Sciences Inc?

What is the current Free Cash Flow
of USANA Health Sciences Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for USANA Health Sciences Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
USANA Health Sciences Inc

Current Assets 451.2m
Cash & Short-Term Investments 364.9m
Other Current Assets 86.3m
Non-Current Assets 220.1m
PP&E 98m
Intangibles 46.4m
Other Non-Current Assets 75.7m
Current Liabilities 114.8m
Accounts Payable 7m
Other Current Liabilities 107.7m
Non-Current Liabilities 23.4m
Other Non-Current Liabilities 23.4m
Efficiency

Earnings Waterfall
USANA Health Sciences Inc

Revenue
862m USD
Cost of Revenue
-165m USD
Gross Profit
697m USD
Operating Expenses
-614.7m USD
Operating Income
82.3m USD
Other Expenses
-28m USD
Net Income
54.3m USD

Free Cash Flow Analysis
USANA Health Sciences Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

USNA Profitability Score
Profitability Due Diligence

USANA Health Sciences Inc's profitability score is 53/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Year Average ROIC
Positive 3-Year Average ROE
Positive Free Cash Flow
53/100
Profitability
Score

USANA Health Sciences Inc's profitability score is 53/100. The higher the profitability score, the more profitable the company is.

USNA Solvency Score
Solvency Due Diligence

USANA Health Sciences Inc's solvency score is 91/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Long-Term Solvency
Low D/E
91/100
Solvency
Score

USANA Health Sciences Inc's solvency score is 91/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

USNA Price Targets Summary
USANA Health Sciences Inc

Wall Street analysts forecast USNA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for USNA is 47.43 USD with a low forecast of 35.35 USD and a high forecast of 60.9 USD.

Lowest
Price Target
35.35 USD
7% Downside
Average
Price Target
47.43 USD
25% Upside
Highest
Price Target
60.9 USD
60% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for USNA?

Click here to dive deeper.

Dividends

USANA Health Sciences Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for USNA is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

USNA Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

USANA Health Sciences Inc Logo
USANA Health Sciences Inc

Country

United States of America

Industry

Consumer products

Market Cap

724.9m USD

Dividend Yield

0%

Description

USANA Health Sciences, Inc. develops and manufactures nutritional, personal care and weight-management products. The company is headquartered in Salt Lake City, Utah and currently employs 1,978 full-time employees. Its product line includes USANA Nutritionals Optimizers, Essentials/CellSentials, Foods, Personal Care and Skincare and All Other. Its USANA Nutritionals Optimizers product line consists of supplements designed to meet individual health and nutritional needs. Its Essentials/CellSentials product line includes vitamin and mineral supplements that provides a total body nutrition for every age group beginning with children 13 months of age. Its Foods product line includes meal replacement shakes, snack bars, and other related products that provides macro-nutrition. Its Personal Care and Skincare product line includes its science-based personal care products and Celavive, its skincare system. Its All Other product line includes materials and online tools that are designed to assist its associates in building their businesses and in marketing its products.

Contact

UTAH
Salt Lake City
3838 W Parkway Blvd
+18019547100.0
www.usana.com

IPO

1993-10-28 00:00:00

Employees

1 978

Officers

Executive Chairman
Mr. Kevin G. Guest
CEO & President
Mr. Jim Brown
Chief Financial Officer
Mr. G. Douglas Hekking
Chief Operating Officer
Mr. Walter Noot
Chief Legal Officer, General Counsel & Corporate Secretary
Mr. P. Joshua Foukas J.D.
Chief Communications & Marketing Officer
Mr. Daniel A. Macuga Jr.
Show More
Founder & Chairman Emeritus
Dr. Myron W. Wentz Ph.D.
Executive Director of Product Development & Technology
Dr. John Cuomo
Chief Scientific Officer
Dr. Robert A. Sinnott M.N.S., Ph.D.
Chief Information Officer
Peter Benedict
Show Less

See Also

Discover More
What is the Intrinsic Value of one USNA stock?

The intrinsic value of one USNA stock under the Base Case scenario is 42.6 USD.

Is USNA stock undervalued or overvalued?

Compared to the current market price of 38.05 USD, USANA Health Sciences Inc is Undervalued by 11%.

Back to Top